Siemens Healthineers cuts outlook, changes leadership team

Siemens Healthineers has lowered its fiscal 2026 outlook and announced changes to its leadership team after reporting pressure in its diagnostics business.

The company released its second-quarter fiscal 2026 results on May 7, with official materials stating that imaging and precision therapy were on track while diagnostics faced a challenging environment.

Siemens Healthineers cut its full-year revenue growth forecast to 4.5% to 5%, down from a previous range of 5% to 6%. Expected earnings per share were lowered to €2.20 to €2.30, compared with the prior range of €2.20 to €2.40.

The diagnostics division was affected by conditions in China, the company’s second-largest market after the U.S. Lwer reimbursement rates and volume-based procurement depressed pricing in the Chinese diagnostics market. The division’s revenue declined 6.5% year over year to €985M.

Inflation also contributed to the revised outlook. Siemens Healthineers expects additional supply chain costs tied partly to memory chips, raw materials, and logistics.

CEO Bernd Montag said the diagnostics division is facing a “perfect storm,” Reuters reported. He also said the company does not necessarily have to remain the owner of the diagnostics business.

Leadership changes will begin June 1, according to MassDevice, which reported details from Montag’s LinkedIn announcement. Andreas Schneck will become head of diagnostic imaging, succeeding André Hartung, who is leaving the company after 25 years.

Schneck has held leadership roles across diagnostic and interventional imaging. His previous roles included leading Siemens Healthineers’ magnetic resonance imaging business in Shenzhen, China, and later the company’s global MRI business.

Advanced therapies will also get new leadership. Philipp Fischer will become head of advanced therapies on June 1, succeeding Carsten Bertram, who is retiring but will support chief technology officer Martin Stumpe until 2027.

Sonja Wehsely will take over the company’s Europe, Middle East, and Africa segment on June 1, replacing Bernd Ohnesorge, who is stepping aside for personal reasons and will remain a senior adviser to the managing board. Elaine Becraft will become chief human resources officer on October 1.

The leadership moves come as parent company Siemens prepares to reduce its stake in Siemens Healthineers. Reuters reported in April that Siemens plans a shareholder vote in February 2027 on a direct spin-off of Siemens Healthineers shares. Siemens currently holds 67% of Siemens Healthineers and plans to transfer 30% to its shareholders, giving up majority ownership.

Siemens said the planned separation and regulatory clarification processes are well advanced, although final regulatory confirmation remains pending. Reuters also noted that Siemens no longer considers medical technology, including X-ray machines and laboratory systems, part of its core business.